6,839
Views
10
CrossRef citations to date
0
Altmetric
Clinical Focus: Cardiometabolic Conditions - Review

Combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists as complementary agents that address multi-organ defects in type 2 diabetes

Pages 555-565 | Received 15 Mar 2019, Accepted 17 Sep 2019, Published online: 03 Oct 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.